电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant TNFSF4 (Oxelumab Biosimilar) 抗体

The Human 单克隆 anti-TNFSF4 (Oxelumab Biosimilar) antibody is suitable to detect TNFSF4 (Oxelumab Biosimilar) in samples from 人. It has been validated for FACS, Func, BLI, ELISA 和 SPR.
产品编号 ABIN7675803
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant TNFSF4 (Oxelumab Biosimilar) 抗体 (ABIN7675803)

抗原

TNFSF4 (Oxelumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 2
  • 1
Human

克隆类型

  • 2
  • 1
单克隆

标记

  • 3
This TNFSF4 (Oxelumab Biosimilar) antibody is un-conjugated

应用范围

Flow Cytometry (FACS), Functional Studies (Func), Bio-Layer Interferometry (BLI), ELISA, Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab)

    序列

    EVQLLESGGG LVQPGGSLRL SCAASGFTFN SYAMSWVRQA PGKGLEWVSI ISGSGGFTYY ADSVKGRFTI SRDNSRTTLY LQMNSLRAED TAVYYCAKDR LVAPGTFDYW GQGALVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG,DIQMTQSPSS LSASVGDRVT ITCRASQGIS SWLAWYQQKP EKAPKSLIYA ASSLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YNSYPYTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

    产品特性

    Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: OX40L inhibitors

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    TNFSF4 (Oxelumab Biosimilar)

    物质类

    Biosimilar

    分子量

    145.5 kDa

    UniProt

    P23510
You are here: